Plant ID: NPO12746
Plant Latin Name: Pleurospermum rivulorum
Taxonomy Genus: Pleurospermum
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
948492
Plant-of-the-World-Online:
847291-1
China
MAPK1; | |
CA13; CA1; CA7; CA12; CA9; | |
ALOX15; ALDH1A1; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2A13 | Cytochrome P450 2A13 | Q16696 | CHEMBL3542436 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Lyase | CA13 | Carbonic anhydrase XIII | Q8N1Q1 | CHEMBL3912 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.674E-13 | 1.941E-09 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 2.587E-12 | 1.127E-08 | CYP1A2, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 7.665E-12 | 2.384E-08 | ALOX15, CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 2.459E-11 | 6.694E-08 | CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.330E-11 | 7.638E-08 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 8.517E-11 | 1.325E-07 | CYP1A2, CYP2A6, CYP2C19, CYP3A4 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 9.562E-11 | 1.388E-07 | CA1, CA12, CA13, CA7, CA9 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.075E-10 | 1.463E-07 | CYP1A2, CYP2A13, CYP2C19, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.163E-10 | 2.771E-07 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.026E-09 | 1.015E-06 | CYP1A2, CYP2A13, CYP2A6, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 1.517E-09 | 1.376E-06 | CYP1A2, CYP2A13, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 1.059E-08 | 7.952E-06 | CYP2A13, CYP2A6, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.258E-08 | 8.835E-06 | CYP1A2, CYP2A13, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 6.642E-08 | 3.806E-05 | CYP1A2, CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 2.049E-07 | 1.062E-04 | CYP2A13, CYP2A6, CYP2C19 |
MF | GO:0003824; catalytic activity | GO:0008389; coumarin 7-hydroxylase activity | 4.878E-07 | 2.452E-04 | CYP2A13, CYP2A6 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 5.983E-07 | 2.772E-04 | CYP1A2, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 1.463E-06 | 6.371E-04 | CYP2D6, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 2.924E-06 | 1.225E-03 | CYP1A2, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 2.188E-05 | 8.075E-03 | CYP1A2, CYP2C19 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 2.496E-05 | 9.058E-03 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2D6, CYP3A4 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 4.627E-13 | 4.581E-11 | CA12, CA1, CA7, CA9, CA13 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 8.241E-10 | 3.629E-08 | CYP2A6, CYP2D6, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.100E-09 | 3.629E-08 | CYP2A6, CYP2A13, CYP2D6, CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.991E-09 | 4.928E-08 | CYP2A6, CYP2A13, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.532E-09 | 6.993E-08 | CYP1A2, ALOX15, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 9.923E-08 | 1.637E-06 | CYP2A6, CYP1A2, ALDH1A1, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 8.933E-07 | 1.263E-05 | CYP2D6, ALOX15, MAPK1, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 1.089E-04 | 1.198E-03 | CYP2A6, CYP1A2, ALOX15, ALDH1A1, CYP2C19, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 8.400E-04 | 6.930E-03 | ALOX15, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 4.627E-04 | 4.581E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 7.355E-04 | 6.619E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 4.545E-06 | 5.624E-05 | CYP2A6, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9; |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | CA9; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | CA9; |